Serotonin transporter function in vivo: assessment by chronoamperometry

Ann N Y Acad Sci. 1998 Dec 15:861:217-29. doi: 10.1111/j.1749-6632.1998.tb10193.x.

Abstract

Local application of selective serotonin reuptake inhibitors, fluvoxamine and citalopram, prolonged the clearance of exogenously administered serotonin (5-HT) in both the dentate gyrus and CA3 region of the dorsal hippocampus, as measured using in vivo chronoamperometry. These effects were abolished in rats pretreated with 5,7-dihydroxytryptamine. The NE uptake inhibitors, desipramine and protriptyline, did not alter the 5-HT signal in the CA3 region, but prolonged the clearance of 5-HT in the dentate gyrus; this effect was absent in rats pretreated with 6-hydroxydopamine. From these data, it is inferred that both the SERT and NET contribute to the active clearance of exogenously applied 5-HT in the dentate gyrus. In another experiment, cyanopindolol, an antagonist of the serotonin terminal autoreceptor, also prolonged the clearance of 5-HT from the CA3 region. These and other data have generated a working hypothesis that activation of the terminal serotonin autoreceptor enhances the kinetics of 5-HT uptake through an effect on the serotonin transporter.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Citalopram / pharmacology
  • Dentate Gyrus / drug effects
  • Dentate Gyrus / physiology
  • Electrochemistry / methods
  • Fluvoxamine / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / physiology*
  • Rats
  • Receptor, Serotonin, 5-HT1B
  • Receptors, Serotonin / physiology*
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Serotonin / metabolism*
  • Signal Transduction

Substances

  • Receptor, Serotonin, 5-HT1B
  • Receptors, Serotonin
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Serotonin
  • Fluvoxamine